PAB
Slow day, but when the expected Deoxymab Cancer breakthrough announcement is released shortly,this will easily do a INL run.At least 4 bags in my view. $3.5M cash equivalent to MV
""Patrys believes that Deoxymab, and its sister antibody, 5C6, may have application across a wide range of malignancies such as gliomas, melanomas, prostate, breast, pancreatic and ovarian cancers."(WORLDWIDE).""
PAB Slow day, but when the expected Deoxymab Cancer breakthrough...
-
- There are more pages in this discussion • 38 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)